![]() |
|
|
Forward to a colleague |
||
Access Full Stories Dutch drug delivery and development company OctoPlus is withdrawing its follow-on financing on its five-strong product portfolio in response to the US mortgage crisis and the struggling stock market... Read Jubilant Organosys eyeing up European acquisitions Indian pharma services provider Jubilant Organosys is looking to buy up European contract research organisations (CRO) and contract research and manufacturing services (CRAMS) and it has got $100m to spend, according... Read Pharmaceutical manufacturing: news in brief In-PharmaTechnologist.com brings you a selection of recent headlines from around the pharmaceutical manufacturing industry... Read A spoonful of foam helps the medicine go down Is it a liquid? Is it a solid?.........No, it's 'foam-on-a-spoon'... Read Merck heads to Ireland for new 200m site Merck has settled on a site in south east Ireland for a new vaccines and biologics facility, investing €200m ($280m) in its third facility on the island... Read |
|||||||||||||||||||
All News Headlines for: November | October | September |
|||||||||||||||||||
![]() SOF'BAG: the airless package to dispense creams, lotions and gels Rexam Pharma presents a total packaging system for transdermal and topical application. The SOF'BAG is easy-to-use for patients while keeping filling simple and logistics easy for drug manufacturers... Click Here | |||||||||||||||||||
Private equity firm puts crores into Indian CRO GVK Bio has reinforced its claim to be India's top CRO with $25m of private investment that will be used to expand its drug discovery services and push further into preclinical and clinical development... Read Xenome and Amylin team up to poison metabolic diseases Xenome, which specialises in extracting therapeutic peptides from the venom of poisonous animals has penned a deal with Amylin Pharmaceuticals to find drugs that tackle metabolic diseases such as diabetes and obesity... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, news has emerged involving ChemDiv, SRI International, ShangPharma, Ranbaxy and Xceleron... Read Targeted Genetics restarts trial after death The US Food and Drug Administration has allowed Targeted Genetics to restart testing its arthritis gene therapy after deciding the drug wasn't at fault when one person died in the original clinical trial... Read
|
|||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||